Finance

Lists
605033:SHA
Shaanxi Meibang Pharmaceuticl Grp Co Ltd
CNÂ¥18.86
+1.07%
(+0.20) 1D
Oct 16, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 605033...
Open
CNÂ¥18.94
High
CNÂ¥19.22
Low
CNÂ¥18.72
Mkt. cap
2.69B
Avg. vol.
3.39M
Volume
1.92M
Dividend
0.80%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jun 17, 2026
P/E ratio
40.10
52-wk high
CNÂ¥34.69
52-wk low
CNÂ¥15.81
EPS
CNÂ¥0.47
No. of employees
1K
Open
CNÂ¥18.94
High
CNÂ¥19.22
Low
CNÂ¥18.72
Mkt. cap
2.69B
Avg. vol.
3.39M
Volume
1.92M
Dividend
0.80%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jun 17, 2026
P/E ratio
40.10
52-wk high
CNÂ¥34.69
52-wk low
CNÂ¥15.81
EPS
CNÂ¥0.47
No. of employees
1K
News stories
From web sources and news partners
About Shaanxi Meibang Pharmaceuticl Grp Co Ltd
CEO-
Employees1.12K
FoundedAug 5, 1998
Headquarters-
SectorFertilizer
Websitemeibang.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
123.56M
303.07M
336.34M
218.60M
Cost of goods sold
79.06M
213.68M
212.57M
141.96M
Cost of revenue
79.06M
213.68M
212.57M
141.96M
Research and development expenses
20.44M
22.88M
20.37M
22.55M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
31.99M
55.73M
49.16M
40.40M
Operating expense
44.93M
77.94M
78.96M
63.87M
Total operating expenses
123.98M
291.63M
291.53M
205.84M
Operating income
-426.70K
11.44M
44.81M
12.77M
Other non operating income
1.27M
-1.41M
248.76K
-134.83K
EBT including unusual items
-786.23K
16.07M
44.95M
15.90M
EBT excluding unusual items
2.49M
12.36M
46.26M
13.90M
Income tax expense
-845.03K
3.60M
9.33M
453.66K
Effective tax rate
107.48%
22.42%
20.75%
2.85%
Other operating expenses
-164.41K
2.54M
1.12M
-2.49M
Net income
58.80K
12.47M
35.62M
15.45M
Net profit margin
0.05%
4.11%
10.59%
7.07%
Earnings per share
-
-
-
-
Interest and investment income
1.69M
2.69M
1.45M
1.36M
Interest expense
-28.67K
-367.68K
-247.12K
-77.30K
Net interest expenses
1.66M
2.32M
1.20M
1.28M
Depreciation and amortization charges
-
-
-
-
EBITDA
4.68M
19.24M
52.61M
24.48M
Gain or loss from assets sale
-42.87K
-187.58K
-
26.40K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps